Communiqués Pharma Foods International Co., Ltd.

Actions

2929

JP3802310007

Recherche biotechnologique et médicale

Marché Fermé - Japan Exchange 08:30:00 25/09/2026			Varia. 5j.	Varia. 1 janv.
718,00 ^JPY	+2,28%		-2,84%	+5,74%

17/09	Pharma Foods International Co., Ltd. publie ses résultats pour l'exercice clos le 31 juillet 2026	CI
11/09	Pharma Foods International Co., Ltd. propose un dividende pour l'exercice clos le 30 juillet 2026, payable le 30 octobre 2026 ; communique ses prévisions de dividende pour la fin du deuxième trimestre et l'exercice clos le 31 juillet 2027	CI

Communiqués

17/09	Pharma Foods International : September 17, 2026 IR 【Correction of Numerical Data】Consolidated Financial Results for the Fiscal Year Ended July 31, 2026 (Under Japanese GAAP)	PU
11/09	Pharma Foods International : September 11, 2026 IR Consolidated Financial Results for the Fiscal Year Ended July 31, 2026 (Under Japanese GAAP)	PU
30/04	Pharma Foods International : April 30, 2026 Research and Development PharmaGABA® New Scientific Study Published in Leading International Journal - Accelerating Global Expansion and Adoption in the Food & Beverage Category	PU
06/04	Pharma Foods International : April 6, 2026 Research and Development Pharma Foods Co., Ltd. Acquires Exclusive Rights to Advance First-in-Class Adrenomedullin Program for CADASIL Across Key Asian Markets	PU
23/03	Pharma Foods International : March 23, 2026 Investor Supplementary Materials of Consolidated Financial Results for the Six Months Ended January 31, 2026	PU
16/02	Pharma Foods International : February 16, 2026 Investor Notice Concerning Dividends of Surplus (Interim Dividend)	PU
11/12	Pharma Foods International : December 11, 2025 Investor Supplementary Materials of Consolidated Financial Results for the Three Months Ended October 31 2025	PU
11/12	Pharma Foods International : December 11, 2025 Investor Consolidated Financial Results for the Three Months Ended October 31, 2025 (Under Japanese GAAP)	PU
13/11	Pharma Foods International : November 13, 2025 Research and Development Pharma Foods Partners with The University of Tokyo For Next-Generation Antibody Drug Discovery ～A Leap Forward with AI and Advanced Molecular Engineering～	PU
30/09/25	Pharma Foods International : September 30, 2025 Investor Notice of the 28th Annual General Meeting of Shareholders	PU
25/09/25	Pharma Foods International : September 25, 2025 Investor Consolidated Financial Results for the Year Ended July 31, 2025 (Based on Japanese GAAP)	PU
24/09/25	Pharma Foods International : September 24, 2025 Research and Development “ALAgene® technology”-Derived Antibody Therapeutic Candidate Achieves Phase I Clinical Milestone ～Driving Future Growth through Strategic License Agreement～	PU
19/09/25	Pharma Foods International : September 19, 2025 Investor Notice Regarding the Board of Directors’ Opinion on a Shareholder Proposal	PU
19/09/25	Pharma Foods International : September 19, 2025 Investor Notice Regarding Partial Amendments to the Articles of Incorporation	PU
11/09/25	Pharma Foods International : September 11, 2025 Investor Consolidated Financial Results for the Fiscal Year Ended July 31, 2025 (Under Japanese GAAP)	PU
04/09/25	Pharma Foods International : September 4, 2025 Investor Notice Regarding Execution of Loan Agreement with Financial Covenants	PU
19/08/25	Pharma Foods International : August 19, 2025 Investor Notice Regarding Construction of a New Plant by Our Consolidated Subsidiary and Execution of a Loan Agreement with Financial Covenants	PU
16/07/25	Pharma Foods International : July 16, 2025 Research and Development Pharma Foods’ Antibody Technology Advances as Takeda Exercises Sequence Purchase Option	PU
16/06/25	Pharma Foods International : June 16, 2025 Investor Notice Regarding Construction of a New Plant by Our Consolidated Subsidiary and Execution of a Loan Agreement with Financial Covenants	PU
10/06/25	Pharma Foods International : June 10, 2025 Investor Supplementary Materials of Consolidated Financial Results for the Nine Months Ended April 30, 2025	PU
10/06/25	Pharma Foods International : June 10, 2025 Investor Consolidated Financial Results for the Nine Months Ended April 30, 2025 (Under Japanese GAAP)	PU
14/05/25	Pharma Foods International : May 14, 2025 Investor Notice Concerning Results of Acquisition of Own Shares Through Off-Auction Own Share Repurchase Trading System (ToSTNeT-3)	PU
13/05/25	Pharma Foods International : May 13, 2025 Investor Notice Concerning Acquisition of Own Shares and Repurchase of Own Shares Through Off-Auction Own Share Repurchase Trading System (ToSTNeT-3)	PU
12/02/25	Pharma Foods International : February 12, 2025 Research and Development The establishment of World's first "CADASIL Drug Discovery Research Department" in collaboration with National Cerebral and Cardiovascular Center	PU
13/12/24	Pharma Foods International : December 13, 2024 Investor (Delayed)Summary of Consolidated Financial Results for the Three Months Ended October 31, 2024 (Based on Japanese GAAP)	PU